Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s):  MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines... see more

CSE:MDMA - Post Discussion

Pharmala Biotech Holdings Inc > did you hold? or add?
View:
Post by Chefboy69 on Jun 14, 2023 1:01pm

did you hold? or add?

if so congrats!!!

NEVER EVER LET EMOTIONS get to you with stocks
Comment by Firepoker on Jun 14, 2023 1:11pm
Or setting up the fall...gone quiet.
Comment by SuperTrader1970 on Jun 14, 2023 2:01pm
Thanks fellas for 26s Harder they fall
Comment by SuperTrader1970 on Jun 15, 2023 11:27am
U people are so stupid. Traders are very dumb
Comment by SuperTrader1970 on Jun 15, 2023 11:29am
Shorts get off MDMA  No More!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities